tiprankstipranks
Q BioMed Inc (QBIO)
OTHER OTC:QBIO
US Market

Q BioMed (QBIO) Financial Statements

101 Followers

Q BioMed Financial Overview

Q BioMed's market cap is currently ―. The company's EPS TTM is $-0.069; its P/E ratio is -0.16; Q BioMed is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 23Nov 22Aug 22May 22Feb 22
Income Statement-
Total Revenue-$ 12.54K$ 26.27K$ 170.49K$ 75.06K
Gross Profit$ -2.50K$ -67.67K$ -40.17K$ 97.74K$ 1.11K
EBIT-$ 1.10M$ -541.45K$ -816.47K$ -1.87M
EBITDA-$ 1.12M$ -528.95K$ -803.97K$ -1.86M
Net Income Common Stockholders$ -721.61K$ 2.18M$ -1.41M$ -1.89M$ -2.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.17K$ 49.97K$ 137.83K$ 27.17K$ 137.18K
Total Assets$ 3.46M$ 3.52M$ 498.03K$ 470.09K$ 538.43K
Total Debt$ 4.08M$ 4.11M$ 3.77M$ 3.42M$ 3.35M
Net Debt$ 4.06M$ 4.06M$ 3.63M$ 3.39M$ 3.21M
Total Liabilities$ 9.91M$ 8.13M$ 7.73M$ 7.56M$ 6.37M
Stockholders Equity$ -6.44M$ -4.62M$ -7.23M$ -7.09M$ -5.83M
Cash Flow-
Free Cash Flow$ -138.19K$ 2.67M$ -239.34K$ -110.02K$ -376.86K
Operating Cash Flow$ -138.19K$ 2.67M$ -239.34K$ -110.02K$ -376.86K
Investing Cash Flow-$ -3.14M---
Financing Cash Flow$ 111.39K$ 387.73K$ 350.00K$ 0.00$ 170.03K
Currency in USD

Q BioMed Earnings and Revenue History

Q BioMed Debt to Assets

Q BioMed Cash Flow

Q BioMed Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis